|
|||
|
Highlights from recent Life Science venture capital news. First Venture Round 02.02.2012 – Menlo Park, CA Auxogyn Completes $20 Million In Series A Funding Auxogyn Inc., a Menlo Park, Calif.-based company that focuses on products for women’s reproductive health, has closed a final tranche in its Series A financing. Investors in the round include Kleiner Perkins Caufield and Byers, . . . → Read More: Life Science Venture Capital Investment News Round Up – 7 February 2012 A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week. Overall Weekly Totals
Total No. Deals NA EU Total Raised $ Total Raised € 90 74 16 616.2 473.0
North America
No. Deals Total $ Total € Average $ Average € 69 582.1 446.8 9.0 6.9 Europe
No. Deals Total $ Total € Average $ Average € 21 34.1 26.2 3.4 2.6
Breakdown By Sector
Life Sciences
No. Deals NA EU Total $ Total € 16 12 4 218.7 167.2 Average Deal NA & . . . → Read More: Venture Capital Investment – 2 February 2011 Highlights from recent IT venture capital investment activity Funding & Investments North America First Venture Round
24.01.2012 – Mountain View, CA Elance Raises Capital to Fuel Growth Elance, the Internet platform used by businesses to gain instant access to 1 million independent workers online, today announced that it has secured $16 Million in expansion capital led by the Stripes . . . → Read More: IT Venture Capital Investment News Round Up – 31 January 2012 Highlights from recent IT venture capital investment activity Funding & Investments North America First Venture Round
24.01.2012 – Mountain View, CA Elance Raises Capital to Fuel Growth Elance, the Internet platform used by businesses to gain instant access to 1 million independent workers online, today announced that it has secured $16 Million in expansion capital led by the Stripes . . . → Read More: IT Venture Capital Investment News Round Up – 31 January 2012 Highlights from recent Life Science venture capital news.
North America
Secondary Venture Round
24.01.2012 – Littleton, MA Leading Private Venture Capital Firms Invest $45 Million in Mevion Medical Systems Mevion Medical Systems announced today that it has closed a $45 Million investment from ProQuest Investments and its existing investors, including Caxton Heath Life Sciences, Venrock and CHL Medical . . . → Read More: Life Science Venture Capital Investment News Round Up – 30 January 2012 Highlights from recent Life Science venture capital news.
North America
Secondary Venture Round
24.01.2012 – Littleton, MA Leading Private Venture Capital Firms Invest $45 Million in Mevion Medical Systems Mevion Medical Systems announced today that it has closed a $45 Million investment from ProQuest Investments and its existing investors, including Caxton Heath Life Sciences, Venrock and CHL Medical . . . → Read More: Life Science Venture Capital Investment News Round Up – 30 January 2012 A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week. Overall Weekly Totals
Total No. Deals NA EU Total Raised $ Total Raised € 67 53 14 467.1 366.3
North America
No. Deals Total $ Total € Average $ Average € 53 446.1 366.3 8.5 6.7 Europe
No. Deals Total $ Total € Average $ Average € 14 20.8 16.3 1.9 1.5
Breakdown By Sector
Life Sciences
No. Deals NA EU Total $ Total € 12 11 1 45.3 35.6 Average Deal NA & EU $ € 4.5 3.6
Largest Deals
Company Name Region Stage $m €m RaNa Therapeutics NA SVR 20.7 16.3 Newtricious EU - - -
TMT
No. Deals NA EU Total $ Total . . . → Read More: Venture Capital Investment – 26 January 2011 Highlights from recent IT venture capital investment activity First Venture Round
17.01.2012 – Minneapolis, MN Accel Leads $52.5M Round In Cloud-Based Data Storage And Backup Company Code 42 Code 42 Software, a Minnesota-based online backup company for consumers, businesses and the enterprise, has raised $52.5 million in funding led by Accel Partners with participation from Split Rock Partners. This . . . → Read More: IT Venture Capital Investment News Round Up – 24 January 2012 Highlights from recent Life Science venture capital news. First Venture Round 18.01.2012 – Cambridge, MA RaNA Therapeutics Closes $20.7M Series A Financing RaNA Therapeutics, a Cambridge, Mass.-based company that is developing drugs by modulating disease-associated long non-coding RNA (lncRNA) and restoring normal expression of individual targeted genes, has completed a $20.7m Series A financing. The round was co-led by . . . → Read More: Life Science Venture Capital Investment News Round Up – 23 January 2012 Highlights from recent Life Science venture capital news. First Venture Round 18.01.2012 – Cambridge, MA RaNA Therapeutics Closes $20.7M Series A Financing RaNA Therapeutics, a Cambridge, Mass.-based company that is developing drugs by modulating disease-associated long non-coding RNA (lncRNA) and restoring normal expression of individual targeted genes, has completed a $20.7m Series A financing. The round was co-led by . . . → Read More: Life Science Venture Capital Investment News Round Up – 23 January 2012 |
||
|
Copyright © 2012 www.mobstr.com - All Rights Reserved |
|||
Comments are closed 